Gastroenterology Coding Alert

Medtronic Now Owns Bravo pH Monitoring System

Endonetics, the medical device company that developed the Bravo pH Monitoring System, was recently acquired by Medtronic. For the prolonged test, 91033 (Esophagus, acid reflux test, with intraluminal pH electrode for detection of gastroe-sophageal reflux; prolonged recording) can be billed with a date of service when the test is completed. It is not necessary to report the code with the date the device is placed. Using the date the data was retrieved assures that indeed the analysis can be done and the 91033 service was provided. This is true for both the Bravo device and for other prolonged monitoring probes. For more on the test, see the September issue of Gastroenterology Coding Alert. For information on the device, contact Mark Traffas, therapy manager, Medtronic Gastroenterology, at (888) 638-7627 or visit www.medtronic.com/neuro/gerd/explainproced.html.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Gastroenterology Coding Alert

View All